Figure 4.
Multivariable Cox proportional hazards analysis of risk factors for UST failure in patients with UC. Hazard ratios of various covariates influencing the risk of UST failure in patients with UC undergoing UST treatment. Concomitant use of IMs is identified as a significant risk factor, while the use of 5-ASA appears to be a protective factor against UST failure. Abbreviation: 5-ASA, 5-aminosalicylic acid; IMs, immunomodulators; UC, ulcerative colitis; UST, ustekinumab.

Multivariable Cox proportional hazards analysis of risk factors for UST failure in patients with UC. Hazard ratios of various covariates influencing the risk of UST failure in patients with UC undergoing UST treatment. Concomitant use of IMs is identified as a significant risk factor, while the use of 5-ASA appears to be a protective factor against UST failure. Abbreviation: 5-ASA, 5-aminosalicylic acid; IMs, immunomodulators; UC, ulcerative colitis; UST, ustekinumab.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close